Codexis Company Profile (NASDAQ:CDXS)

About Codexis (NASDAQ:CDXS)

Codexis logoCodexis, Inc. is a developer of biocatalysts for the pharmaceutical and fine chemicals markets. The Company's CodeEvolver protein engineering technology platform, which introduces genetic mutations into genes in order to give rise to changes in the enzymes that they produce, overcomes many of the limitations, allowing customers to evolve and optimize biocatalysts to perform specific and desired chemical reactions at commercial scale. The Company's pharmaceutical products include enzymes, pharmaceutical intermediates, active pharmaceutical ingredients (APIs) and Codex Biocatalyst Panels and Kits. The fine chemicals market consists of several market verticals, including food and food ingredients, animal feed, flavors and fragrances, and agricultural chemicals. The Company also uses its technology to develop an early stage, enzyme therapeutic product candidate for the treatment of phenylketonuria (PKU) in humans through oral administration.

Industry, Sector and Symbol:
  • Sector: Industrial Products
  • Industry: Biotechnology & Medical Research
  • Sub-Industry: Biotechnology
  • Symbol: NASDAQ:CDXS
  • CUSIP: 19200510
  • Web: www.codexis.com
Capitalization:
  • Market Cap: $355.18 million
  • Outstanding Shares: 48,324,000
Average Prices:
  • 50 Day Moving Avg: $6.17
  • 200 Day Moving Avg: $5.20
  • 52 Week Range: $3.60 - $7.95
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -40.83
  • P/E Growth: -1.16
Sales & Book Value:
  • Annual Revenue: $43.16 million
  • Price / Sales: 8.23
  • Book Value: $0.63 per share
  • Price / Book: 11.67
Profitability:
  • EBITDA: ($15,160,000.00)
  • Net Margins: -40.70%
  • Return on Equity: -83.39%
  • Return on Assets: -45.44%
Debt:
  • Current Ratio: 3.06%
  • Quick Ratio: 2.99%
Misc:
  • Average Volume: 170,353 shs.
  • Beta: -1.44
  • Short Ratio: 14.32
 

Frequently Asked Questions for Codexis (NASDAQ:CDXS)

What is Codexis' stock symbol?

Codexis trades on the NASDAQ under the ticker symbol "CDXS."

How were Codexis' earnings last quarter?

Codexis, Inc. (NASDAQ:CDXS) posted its quarterly earnings data on Wednesday, August, 9th. The company reported ($0.13) earnings per share (EPS) for the quarter, hitting the Zacks' consensus estimate of ($0.13). The firm had revenue of $10.30 million for the quarter, compared to the consensus estimate of $9.61 million. Codexis had a negative net margin of 40.70% and a negative return on equity of 83.39%. The business's revenue for the quarter was down 35.6% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.12 EPS. View Codexis' Earnings History.

When will Codexis make its next earnings announcement?

Codexis is scheduled to release their next quarterly earnings announcement on Monday, November, 6th 2017. View Earnings Estimates for Codexis.

Where is Codexis' stock going? Where will Codexis' stock price be in 2017?

4 brokers have issued 12 month price objectives for Codexis' shares. Their predictions range from $5.50 to $11.00. On average, they expect Codexis' share price to reach $7.81 in the next twelve months. View Analyst Ratings for Codexis.

Who are some of Codexis' key competitors?

Who are Codexis' key executives?

Codexis' management team includes the folowing people:

  • Bernard J. Kelley, Chairman of the Board
  • John J. Nicols, President, Chief Executive Officer, Director
  • Gordon T. Sangster, Chief Financial Officer, Senior Vice President
  • Douglas T. Sheehy J.D., Executive Vice President, Chief Administrative Officer, General Counsel, Secretary
  • Michael Douglas Arthur Aldridge, Senior Vice President - Corporate & Strategic Development
  • James Lalonde, Senior Vice President, Research & Development
  • Thomas R. Baruch J.D., Chairman Emeritus
  • Pam P. Cheng, Director
  • Kathleen Sereda Glaub, Director
  • Patrick Y. Yang, Director

Who owns Codexis stock?

Codexis' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include VIVO VENTURES VII, LLC (6.30%). Company insiders that own Codexis stock include Bernard J Kelley, Dennis P Wolf, James Lalonde, Patrick Y Yang, Ventures Fund Vii LP Vivo, Ventures Vii Affiliates F Vivo and Vivo Ventures Vii, Llc. View Institutional Ownership Trends for Codexis.

How do I buy Codexis stock?

Shares of Codexis can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Codexis' stock price today?

One share of Codexis stock can currently be purchased for approximately $7.35.


MarketBeat Community Rating for Codexis (NASDAQ CDXS)
Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  112 (Vote Outperform)
Underperform Votes:  128 (Vote Underperform)
Total Votes:  240
MarketBeat's community ratings are surveys of what our community members think about Codexis and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Codexis (NASDAQ:CDXS) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Hold Rating, 3 Buy Ratings
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $7.81 (6.29% upside)
Consensus Price Target History for Codexis (NASDAQ:CDXS)
Price Target History for Codexis (NASDAQ:CDXS)
Analysts' Ratings History for Codexis (NASDAQ:CDXS)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/13/2017Jefferies Group LLCBoost Price TargetBuy$9.00 -> $11.00N/AView Rating Details
10/13/2017HC WainwrightBoost Price TargetBuy -> Buy$8.00 -> $8.50N/AView Rating Details
1/26/2017First AnalysisDowngradeOverweight -> Equal Weight$5.50N/AView Rating Details
1/4/2017Ladenburg Thalmann Financial ServicesUpgradeNeutral -> Buy$6.25N/AView Rating Details
(Data available from 10/17/2015 forward)

Earnings

Earnings History for Codexis (NASDAQ:CDXS)
Earnings by Quarter for Codexis (NASDAQ:CDXS)
Earnings History by Quarter for Codexis (NASDAQ CDXS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/6/2017($0.17)N/AView Earnings Details
8/9/2017Q2 2017($0.13)($0.13)$9.61 million$10.30 millionViewListenView Earnings Details
5/9/2017Q1 2017($0.15)($0.18)$9.23 million$7.97 millionViewListenView Earnings Details
3/9/2017Q4 2016($0.11)($0.12)$9.15 million$10.00 millionViewListenView Earnings Details
11/8/2016Q3($0.14)$0.06$7.41 million$14.90 millionViewListenView Earnings Details
8/9/2016Q216$0.03$0.12$15.10 million$16.00 millionViewListenView Earnings Details
5/9/2016Q1($0.15)($0.11)$7.49 million$8.00 millionViewListenView Earnings Details
3/3/2016Q4($0.04)$0.02$11.63 million$11.60 millionViewN/AView Earnings Details
11/4/2015Q315($0.11)$0.13$8.85 million$17.40 millionViewListenView Earnings Details
8/11/2015Q215($0.14)($0.14)$7.34 million$6.02 millionViewListenView Earnings Details
5/7/2015Q115($0.12)($0.14)$8.00 million$6.80 millionViewListenView Earnings Details
3/3/2015Q414$0.01$0.07$13.30 million$14.20 millionViewListenView Earnings Details
11/4/2014Q314($0.06)($0.05)$9.00 million$7.47 millionViewListenView Earnings Details
8/6/2014Q214($0.15)($0.22)$8.50 million$6.60 millionViewListenView Earnings Details
5/7/2014Q114($0.10)($0.17)$10.00 million$7.10 millionViewListenView Earnings Details
3/11/2014Q413($0.21)($0.26)$10.00 million$9.50 millionViewListenView Earnings Details
11/12/2013Q313($0.31)($0.24)$8.50 million$3.90 millionViewListenView Earnings Details
8/9/2013Q2 2013($0.28)($0.33)$9.00 million$6.97 millionViewListenView Earnings Details
5/7/2013Q1 2013($0.36)($0.25)$7.63 million$11.48 millionViewListenView Earnings Details
2/27/2013Q4 2012($0.34)($0.41)$9.33 million$7.90 millionViewListenView Earnings Details
11/7/2012Q312($0.15)($0.06)$25.88 million$26.34 millionViewN/AView Earnings Details
8/9/2012($0.18)($0.15)ViewN/AView Earnings Details
5/10/2012($0.15)($0.21)ViewN/AView Earnings Details
2/7/2012($0.11)($0.15)ViewN/AView Earnings Details
11/1/2011($0.08)($0.08)ViewN/AView Earnings Details
7/28/2011($0.10)($0.14)ViewN/AView Earnings Details
5/5/2011($0.07)($0.10)ViewN/AView Earnings Details
2/3/2011($0.06)($0.01)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Codexis (NASDAQ:CDXS)
2017 EPS Consensus Estimate: ($0.35)
2018 EPS Consensus Estimate: ($0.13)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171($0.10)($0.10)($0.10)
Q2 20172($0.14)($0.12)($0.13)
Q3 20172($0.17)($0.14)($0.16)
Q4 20171$0.04$0.04$0.04
Q1 20181($0.13)($0.13)($0.13)
Q2 20181($0.13)($0.13)($0.13)
Q3 20181($0.07)($0.07)($0.07)
Q4 20181$0.20$0.20$0.20
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Codexis (NASDAQ:CDXS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Codexis (NASDAQ:CDXS)
Insider Ownership Percentage: 9.80%
Institutional Ownership Percentage: 63.62%
Insider Trades by Quarter for Codexis (NASDAQ:CDXS)
Institutional Ownership by Quarter for Codexis (NASDAQ:CDXS)
Insider Trades by Quarter for Codexis (NASDAQ:CDXS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/14/2017Ventures Vii Affiliates F VivoMajor ShareholderSell1,060,000$5.78$6,126,800.00View SEC Filing  
11/15/2016Patrick Y YangDirectorBuy10,000$4.83$48,300.00View SEC Filing  
9/8/2016Ventures Fund Vii L.P. VivoMajor ShareholderSell111,600$4.25$474,300.00View SEC Filing  
8/29/2016Dennis P WolfDirectorSell18,000$4.22$75,960.00View SEC Filing  
8/24/2016Bernard J KelleyDirectorSell12,643$4.26$53,859.18View SEC Filing  
8/16/2016Ventures Fund Vii L.P. VivoMajor ShareholderSell86,894$4.25$369,299.50View SEC Filing  
8/15/2016Vivo Ventures Vii, LlcMajor ShareholderSell50,000$4.27$213,500.00View SEC Filing  
8/4/2016Ventures Fund Vii L.P. VivoMajor ShareholderSell80,000$4.22$337,600.00View SEC Filing  
11/11/2015James LalondeSVPSell9,441$3.52$33,232.32View SEC Filing  
9/11/2015Patrick Y YangDirectorBuy10,000$3.47$34,700.00View SEC Filing  
9/10/2015Bernard J. KelleyDirectorSell5,200$3.45$17,940.00View SEC Filing  
8/24/2015Patrick Y YangDirectorBuy10,000$3.84$38,400.00View SEC Filing  
8/14/2015Patrick Y YangDirectorBuy20,000$3.97$79,400.00View SEC Filing  
6/15/2015Dennis P WolfDirectorSell35,416$4.10$145,205.60View SEC Filing  
11/18/2014Patrick Y YangDirectorBuy20,000$2.35$47,000.00View SEC Filing  
11/17/2014Patrick Y YangDirectorBuy20,000$2.34$46,800.00View SEC Filing  
8/12/2014Patrick Y YangDirectorBuy60,000$2.22$133,200.00View SEC Filing  
3/8/2013John J NicolsCEOBuy27,000$2.42$65,340.00View SEC Filing  
3/7/2013John J NicolsCEOBuy54,000$2.22$119,880.00View SEC Filing  
3/4/2013David D O'tooleCFOBuy10,000$2.02$20,200.00View SEC Filing  
11/12/2012David D O'tooleCFOBuy5,000$2.20$11,000.00View SEC Filing  
9/14/2012David D O'tooleCFOBuy5,000$2.78$13,900.00View SEC Filing  
9/14/2012Douglas T SheehySVPSell3,800$2.76$10,488.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Codexis (NASDAQ:CDXS)
Latest Headlines for Codexis (NASDAQ:CDXS)
Source:
DateHeadline
americanbankingnews.com logoCodexis, Inc. (CDXS) Expected to Announce Quarterly Sales of $10.00 Million
www.americanbankingnews.com - October 17 at 2:02 AM
americanbankingnews.com logoAnalysts Issue Forecasts for Codexis, Inc.'s Q4 2017 Earnings (CDXS)
www.americanbankingnews.com - October 16 at 5:18 AM
americanbankingnews.com logoCodexis, Inc. (CDXS) Price Target Raised to $11.00
www.americanbankingnews.com - October 13 at 7:02 PM
thestreet.com logoCodexis Reaches Analyst Target Price
www.thestreet.com - October 13 at 5:41 PM
americanbankingnews.com logoHC Wainwright Boosts Codexis, Inc. (CDXS) Price Target to $8.50
www.americanbankingnews.com - October 13 at 7:34 AM
thestreet.com logoCodexis And Nestle Health Science Enter Into Healthcare-Focused Protein Engineering Platform Partnership
www.thestreet.com - October 12 at 10:55 PM
finance.yahoo.com logoCodexis and Nestlé Health Science Enter Into Healthcare-Focused Protein Engineering Platform Partnership
finance.yahoo.com - October 12 at 5:53 PM
finance.yahoo.com logoETFs with exposure to Codexis, Inc. : October 12, 2017
finance.yahoo.com - October 12 at 5:53 PM
finance.yahoo.com logoCodexis, Inc. :CDXS-US: Earnings Analysis: Q2, 2017 By the Numbers : October 11, 2017
finance.yahoo.com - October 11 at 6:34 PM
americanbankingnews.com logoCodexis, Inc. (CDXS) Upgraded to Hold by Zacks Investment Research
www.americanbankingnews.com - October 11 at 5:56 PM
finance.yahoo.com logo3 Top Small-Cap Stocks to Buy in October
finance.yahoo.com - October 4 at 12:23 PM
americanbankingnews.com logoCodexis, Inc. (CDXS) Rating Reiterated by Jefferies Group LLC
www.americanbankingnews.com - October 2 at 3:50 PM
americanbankingnews.com logoCodexis, Inc. (CDXS) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - October 1 at 2:50 AM
americanbankingnews.com logoCodexis, Inc. (CDXS) Expected to Announce Earnings of -$0.14 Per Share
www.americanbankingnews.com - September 27 at 6:20 AM
americanbankingnews.com logoCodexis (CDXS) & Bio-Techne Corp (TECH) Head to Head Analysis
www.americanbankingnews.com - September 20 at 2:22 PM
americanbankingnews.com logoCodexis, Inc. (CDXS) Major Shareholder Ventures Vii Affiliates F. Vivo Sells 1,060,000 Shares
www.americanbankingnews.com - September 18 at 10:26 PM
americanbankingnews.com logoComparing Codexis (CDXS) and Its Rivals
www.americanbankingnews.com - September 17 at 10:32 PM
americanbankingnews.com logo$10.00 Million in Sales Expected for Codexis, Inc. (CDXS) This Quarter
www.americanbankingnews.com - September 10 at 5:40 AM
seekingalpha.com logoCodexis (CDXS) Presents At 24th Annual NewsMakers In The Biotech Industry - Slideshow
seekingalpha.com - September 9 at 9:44 PM
americanbankingnews.com logo-$0.14 Earnings Per Share Expected for Codexis, Inc. (CDXS) This Quarter
www.americanbankingnews.com - September 8 at 2:20 PM
americanbankingnews.com logoCodexis, Inc. (CDXS) Given Consensus Rating of "Hold" by Brokerages
www.americanbankingnews.com - September 6 at 2:28 AM
finance.yahoo.com logoCodexis to Present at Four Investment Conferences in September
finance.yahoo.com - August 31 at 4:58 PM
fool.com logo3 Stocks Set to Pop
www.fool.com - August 16 at 2:24 PM
americanbankingnews.com logoFinancial Comparison: Codexis (NASDAQ:CDXS) & Repros Therapeutics (RPRX)
www.americanbankingnews.com - August 14 at 8:06 PM
americanbankingnews.com logoQ3 2017 EPS Estimates for Codexis, Inc. (NASDAQ:CDXS) Lowered by Jefferies Group
www.americanbankingnews.com - August 14 at 3:34 AM
americanbankingnews.com logoHC Wainwright Analysts Give Codexis, Inc. (NASDAQ:CDXS) a $8.00 Price Target
www.americanbankingnews.com - August 13 at 3:32 PM
americanbankingnews.com logoCodexis, Inc. (NASDAQ:CDXS) Receives Consensus Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - August 12 at 2:32 AM
americanbankingnews.com logoJefferies Group Brokers Reduce Earnings Estimates for Codexis, Inc. (CDXS)
www.americanbankingnews.com - August 11 at 1:22 PM
finance.yahoo.com logoEdited Transcript of CDXS earnings conference call or presentation 9-Aug-17 8:30pm GMT
finance.yahoo.com - August 10 at 6:17 PM
americanbankingnews.com logoCodexis, Inc. (CDXS) Posts Quarterly Earnings Results, Beats Expectations By $0.03 EPS
www.americanbankingnews.com - August 9 at 11:16 PM
finance.yahoo.com logoCodexis reports 2Q loss
finance.yahoo.com - August 9 at 10:18 PM
finance.yahoo.com logoCodexis Reports Financial Results for the Second Quarter of 2017
finance.yahoo.com - August 9 at 5:14 PM
streetinsider.com logoCodexis (CDXS) Says Court Ordered Summary Judgment of Patent Infringement against EnzymeWorks
www.streetinsider.com - August 9 at 2:53 AM
finance.yahoo.com logoCodexis Obtains Court Order Awarding Summary Judgment of Patent Infringement against EnzymeWorks
finance.yahoo.com - August 8 at 4:47 PM
feeds.benzinga.com logoCodexis to Hold 2017 Second Quarter Conference Call on August 9
feeds.benzinga.com - August 2 at 8:21 AM
americanbankingnews.com logoCodexis, Inc. (NASDAQ:CDXS) Receives Consensus Rating of "Hold" from Brokerages
www.americanbankingnews.com - July 18 at 1:45 PM
americanbankingnews.com logo$10.04 Million in Sales Expected for Codexis, Inc. (CDXS) This Quarter
www.americanbankingnews.com - July 13 at 11:04 AM
finance.yahoo.com logoETFs with exposure to Codexis, Inc. : July 11, 2017
finance.yahoo.com - July 11 at 6:04 PM
americanbankingnews.com logo Analysts Anticipate Codexis, Inc. (CDXS) Will Post Earnings of -$0.13 Per Share
www.americanbankingnews.com - July 11 at 12:22 PM
marketbeat.com logoCodexis reports 1Q loss
marketbeat.com - May 9 at 7:04 PM
seekingalpha.com logoDelta Technology Holdings Is A Deep Value Play On The Fine Chemical Industry Rebound In China
seekingalpha.com - May 2 at 3:59 PM
streetinsider.com logoCodexis (CDXS) Secures 2nd Multi-Year Agreement in Food Industry with Tate & Lyle
www.streetinsider.com - March 31 at 9:23 PM
capitalcube.com logoCodexis, Inc. :CDXS-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017
us.rd.yahoo.com - March 15 at 4:35 PM
biz.yahoo.com logoQ4 2016 Codexis Inc Earnings Release - After Market Close
biz.yahoo.com - March 9 at 4:48 PM
biz.yahoo.com logoCODEXIS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
biz.yahoo.com - March 9 at 4:48 PM
biz.yahoo.com logoCodexis Inc Earnings Call scheduled for 4:30 pm ET today
biz.yahoo.com - March 9 at 4:48 PM
feeds.benzinga.com logoCodexis to Hold 2016 Fourth Quarter and Full Year Conference Call on March 9
feeds.benzinga.com - March 2 at 7:54 AM
nasdaq.com logoWhat's in Store for KBR Inc. (KBR) this Earnings Season?
www.nasdaq.com - February 21 at 2:25 PM
nasdaq.com logoDeere (DE) Q1 Earnings: A Beat in Store for the Stock?
www.nasdaq.com - February 13 at 4:49 PM
marketwatch.com logoCodexis to Commercially Supply Proprietary Enzyme to Tate & Lyle
www.marketwatch.com - December 6 at 12:02 PM

Social

Chart

Codexis (CDXS) Chart for Tuesday, October, 17, 2017

This page was last updated on 10/17/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.